Evidence map›Paper›PMID 30552338›Full record

ArticleScientific reports2018

The frequencies of micronuclei, nucleoplasmic bridges and nuclear buds as biomarkers of genomic instability in patients with urothelial cell carcinoma.

Arjeta Podrimaj-Bytyqi, Ana Borovečki, Qerim Selimi, Suzana Manxhuka-Kerliu, Goneta Gashi, Isa R Elezaj

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Micronuclei and Cancer.Cancer discovery · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Arjeta Podrimaj-BytyqiInstitute of Pathology, Faculty of Medicine, University of Pristina "Hasan Prishtina", Pristina, Kosovo. arjeta.podrimaj@uni-pr.edu.
Ana BorovečkiInstitute of Pathology "Enge", Zürich, Switzerland.
Qerim SelimiDepartament of Biology, Faculty of Natural Sciences, University of Pristina "Hasan Prishtina", Pristina, Kosovo.
Suzana Manxhuka-KerliuInstitute of Pathology, Faculty of Medicine, University of Pristina "Hasan Prishtina", Pristina, Kosovo.
Goneta GashiInstitute of Pathology, Faculty of Medicine, University of Pristina "Hasan Prishtina", Pristina, Kosovo.
Isa R ElezajDepartament of Biology, Faculty of Natural Sciences, University of Pristina "Hasan Prishtina", Pristina, Kosovo.
University of Prishtina · XKUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder urothelial cell carcinoma (UCC) is an increasingly prevalent cancer worldwide, and thus, gaining a better understanding of its identifiable risk factors is a global priority. This study addressed this public health need with the understanding that cancer-initiating events, such as chromosome breakage, loss and rearrangement, can be reasonably used as biomarkers to evaluate an individual's cancer risk. Overall, forty bladder cancer patients and twenty controls were evaluated for genomic instability. To the best of the investigators' knowledge, this is the first study to perform micronucleus (MN) assays simultaneously in urothelial exfoliated cells (UEC), buccal exfoliated cells (BEC), and peripheral blood lymphocytes (PBL) in first-diagnosed, non-smoker bladder UCC patients. Additionally, the frequency of nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) in PBL was evaluated. The MN frequencies in UEC, BEC, and PBL, as well as the frequencies of NPBs and NBUDs, were significantly higher in patients than in controls. In conclusion, MN assays, particularly in UEC, may be used to identify individuals who are at high risk of developing UCC, as single or as additional triage test to UroVysion FISH test. Our results further validate the efficacy of biomarkers, such as MN, NPBs, and NBUDs, as predictors of genomic instability.

Indexed as

Genomic InstabilityAdultAgedBiomarkers, TumorCarcinomaCell NucleusEpithelial CellsHumansLymphocytesMaleMiddle AgedMouth MucosaUrinary Bladder NeoplasmsUrotheliumBiomarkers, Tumor

Identifiers

PMID30552338
PMCPMC6294807
OpenAlexW2904061818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.